Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.43 |
| ▸ | ARG2 | P78540 | 4/20 | 0.42 |
| ▸ | ARG1 | P05089 | 3/20 | 0.42 |
| ▸ | OTC | P00480 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 4/20 | 0.38 |
| ▸ | NOS3 | P29474 | 2/20 | 0.38 |
| ▸ | NOS1 | P29475 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9255742 | 0.78 | GSR (0.50) | GSRDDAH1ARG2ARG1OTC | |
| SCHEMBL3385726 | 0.78 | GRIK1 (0.39) | GSRPMP22CYP1A2 | |
| Hydrochloric Acid SCHEMBL21875953 | 0.77 | PMP22 (0.49) | GSRDDAH1ARG2ARG1OTC | |
| SCHEMBL20445992 | 0.73 | ZDHHC20 (0.51) | GSRDDAH1ARG2ARG1OTC | |
| Lysine SCHEMBL14876567 | 0.73 | GSR (0.69) | GSRARG2ARG1PMP22NOS2 | |
| SCHEMBL6817462 | 0.73 | ZDHHC20 (0.51) | GSRDDAH1ARG2ARG1OTC | |
| SCHEMBL10507212 | 0.73 | ZDHHC20 (0.51) | GSRDDAH1ARG2ARG1OTC | |
| Lysine SCHEMBL14876564 | 0.73 | GSR (0.69) | GSRARG2ARG1PMP22NOS2 | |
| SCHEMBL20446016 | 0.73 | ZDHHC20 (0.51) | GSRDDAH1ARG2ARG1OTC | |
| SCHEMBL25724508 | 0.73 | GSR (0.48) | GSRDDAH1ARG2ARG1OTC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12460317-B2 | Genetically encoded, phage-displayed cyclic peptide library and methods of making the same | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-11-04 | — | — | US | disclosed |
| US-20230139680-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2023-05-04 | — | — | US | disclosed |
| EP-3972625-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | The Texas A&M University System (US) | 2022-03-30 | — | — | EP | disclosed |
| CN-113727725-A | Genetically encoded phage-displayed cyclic peptide libraries and methods of making the same | 得克萨斯A&M大学系统 | 2021-11-30 | — | — | CN | disclosed |
| WO-2020236146-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2020-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139680-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | QPCTL, LNPEP, QPCT | GSR 3985/4885DDAH1 1509/4885ARG2 1682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.